The following was sent to me as a comment to a prior post. Instead, I think the comment warrants being put up as its own separate post. It is written by a urologist who has requested that I only use his initials instead of his full name. I would like to thank you for your [...]
Some interesting information was presented at the Society of Interventional Radiology’s 35th Annual Scientific Meeting just held in Tampa, Fl. A potential future use of magnetic resonance (MR)-guided heat (laser interstitial thermal therapy) or cold (cryoablation) to treat the recurrence of prostate cancer after the surgical removal of the prostate gland (and in some cases [...]
The doctors told me that I have recurrent prostate cancer, they stamped on my forehead a little sign that says “EXPIRES ??/??/20??. I have tried and tried to wash that stamp off my face. No matter what I do it still remains, setting me apart from everyone else. I am not ready to expire nor [...]
Roche Pharmaceuticals has reported that their clinical trial of Avastin in men with advanced prostate cancer did not improve their overall life expectancy. […]
Watson Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Trelstar – 22.5 mg (triptorelin pamoate for injectable suspension) at a dosage which will be required only to be administered twice a year. […]
The old adage, prostate cancer is the cancer that you die with not the cancer you die from has been around for a long time. No question compared too many other cancers prostate cancer does progress more slowly than many other cancers. But, is this adage true? Men with prostate cancer have competing mortality risks [...]
The drug is called Cabazitaxel, (it will be named Jevtana) and is made by the French company Sanofi-Aventis SA. Cabazitaxel is a chemical cousin of Taxotere (the current standard of care) and it is designed to evade the mechanism that cancer cells use to resist Taxotere, so we can assume that initially it would be [...]
I spent most of today listening to the Congressional Hearing on Prostate Cancer. I spent most of today listening to a travesty for men with advanced prostate cancer. I believe that today's hearing pushed men with advanced prostate cancer ten steps backwards. PSA testing, PSA testing is all we heard. Important, yes, but so are [...]
We know that docetaxel chemotherapy (chemo) extends life, but which men might hope to experience an increase in survival? The Department of Urology, All India Institute of Medical Sciences, New Delhi, India performed a small study designed to evaluate the efficacy of docetaxel/prednisone and zoledronic acid in the treatment of men with hormone refractory prostate [...]
In a Town Hall discussion, “Ablating Testosterone in Prostate Cancer and the Concomitant Negative Effects”, Fred Saad, MD, FRCS, Director of Urologic Oncology, Professor of Surgery/Urology, U of M Chair in Prostate Cancer; University of Montreal discussed the negative effects that bone loss resulting from hormone therapy (ADT) poses to our life expectancy. His over [...]
